ALL ABOUT DAILYZ HEALTH NEWS
ALL ABOUT DAILYZ HEALTH NEWS
The FDA will reconsider Atara Biotherapeutics’ rare cancer drug Ebvallo after initially rejecting it due to manufacturing concerns.
The FDA will reconsider Atara Biotherapeutics’ rare cancer drug Ebvallo after initially rejecting it due to manufacturing concerns.
The FDA will reconsider Atara Biotherapeutics’ rare cancer drug Ebvallo after initially rejecting it due to manufacturing concerns.
The FDA will reconsider Atara Biotherapeutics’ rare cancer drug Ebvallo after initially rejecting it due to manufacturing concerns.
The FDA will reconsider Atara Biotherapeutics’ rare cancer drug Ebvallo after initially rejecting it due to manufacturing concerns.
The FDA will reconsider Atara Biotherapeutics’ rare cancer drug Ebvallo after initially rejecting it due to manufacturing concerns.
Read More
Representatives Miller-Meeks and Conaway introduced H.R. 8622 to reform Medicare’s MIPS by freezing thresholds, reducing penalties, and enhancing physician feedback.
Read More
Scientists isolated potent measles-blocking antibodies from a vaccinated patient, showing preventive and treatment effects in rodent models amid U.S. resurgence.
Read More
A 2026 study found abdominal muscle contractions cause brain sway by altering blood flow and cerebrospinal fluid movement in mice.
Read More
A UK study found nature-based group activities in care homes improve residents’ mental health by reducing stress, anxiety, and loneliness.
Read More
Nebraska became the first state to enforce Medicaid work requirements, mandating 80 hours monthly for able-bodied enrollees without dependents.
Read More
Colorectal cancer screening rates rose significantly among insured adults aged 45-49 after USPSTF lowered the recommended screening age in 2021.
Read More
The AMA released a policy framework to combat AI deepfakes impersonating physicians, enhancing identity protections and addressing legal gaps.
Read More
President Trump signed an executive order to expedite FDA approval of psychedelic drugs for serious mental illness treatment in the U.S.
Read More
A Chinese trial of over 11,000 hypertensive patients found intensive blood pressure control below 120 mm Hg safe for cognition and reduced cardiovascular events.
Read More
